Obstetric Complications During Pregnancy

  • Mindy A. Smith


Four complications of pregnancy are reviewed here: spontaneous abortion, ectopic pregnancy, hypertension associated with pregnancy, and preterm labor. Changes in the understanding of the pathophysiology, diagnosis, and management of these conditions are highlighted.


Preterm Birth Ectopic Pregnancy Magnesium Sulfate Preterm Labor Obstetric Complication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Simpson JL. Incidence and timing of pregnancy losses: relevance to evaluating safety of early prenatal diagnosis. Am J Med Genet 1990;35:165–73.PubMedCrossRefGoogle Scholar
  2. 2.
    Christiaens GCML, Stoutenbeek PH. Spontaneous abortion in proven intact pregnancies. Lancet 1984;2:571–2.PubMedCrossRefGoogle Scholar
  3. 3.
    Simpson JL, Mills JL, Holmes LB, et al. Low fetal loss rates after ultrasound-proved viability in early pregnancy. JAMA 1987;258: 2555–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Stirrat GM. Recurrent miscarriage. I. Definition and epidemiology. Lancet 1990;336:673–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Tulppala M, Ylikorkala O. Recurrent spontaneous abortion: Where do we stand now? Ann Med 1991;23:603–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Bauld R, Sutherland GR, Bain AD. Chromosomal studies in investigation of stillbirths and neonatal deaths. Arch Dis Child 1974;49: 782–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Kline J, Shrout P, Stein ZA, Süsser M, Warburton D. Drinking during pregnancy and spontaneous abortion. Lancet 1980;2:176–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Parazzini F, Bocciolone L, LaVecchia C, Negri E, Fedale L. Maternal and paternal moderate daily alcohol consumption and unexplained miscarriages. Br J Obstet Gynaecol 1990;97:618–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Stirrat GM. Recurrent miscarriage. II. Clinical associations, causes and management. Lancet 1990;336:728–33.PubMedCrossRefGoogle Scholar
  10. 10.
    Tulppala M, Björses U-M, Stenman U-H, Wahlström T, Ylikorkala O. Luteal phase defect in habitual abortion: progesterone in saliva. Fertil Steril 1991;56:41–44.PubMedGoogle Scholar
  11. 11.
    Sagle M, Bishop K, Ridley N, et al. Recurrent early miscarriage and polycystic ovaries. BMJ 1988;297:1027–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Hertz JB. Diagnostic procedures in threatened abortion. Obstet Gynecol 1984;64:223–9.PubMedGoogle Scholar
  13. 13.
    Spontaneous abortion in primary care: a report from ASPN. Am Board Fam Pract 1988;1:15–23.Google Scholar
  14. 14.
    Fruzzetti F, Melis GB, deCecco L, et al. The use of 16, 16-di-methyl-trans-A2 prostaglandin E1 methylester vaginal suppositories for management of missed abortion and fetal death. Int J Gynaecol Obstet 1991;26:115–19.CrossRefGoogle Scholar
  15. 15.
    Liddell HS, Pattison NS, Zanderigo A. Recurrent miscarriage— outcome after supportive care in early pregnancy. Aust NZ J Obstet Gynaecol 1991;31:320–2.CrossRefGoogle Scholar
  16. 16.
    Ectopic pregnancy surveillance: United States 1970–1987. MMWR 1988;39 SS-4:9–17.Google Scholar
  17. 17.
    Chow JM, Yonekura ML, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy: a matched-pair, case-control study. JAMA 1990;263:3164–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Pauerstein CJ, Croxatto HB, Eddy CA, Ramzy I, Walters MD. Anatomy and pathology of tubal pregnancy. Obstet Gynecol 1986; 67:301–8.PubMedGoogle Scholar
  19. 19.
    Coste J, Job-Spira N, Fernandez H. Increased risk of ectopic pregnancy with maternal cigarette smoking. Am J Public Health 1991; 81:199–201.PubMedCrossRefGoogle Scholar
  20. 20.
    Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol 1991;78:291–8.PubMedGoogle Scholar
  21. 21.
    Herbertson RM, Storey ND. Ectopic pregnancy. Crit Care Clin 1991;7:899–915.Google Scholar
  22. 22.
    Helvacioglu A, Long EM, Yang SL. Ectopic pregnancy: an eight-year review. J Reprod Med 1979;22:87–92.PubMedGoogle Scholar
  23. 23.
    Breen JL. A 21-year study of 654 ectopic pregnancies. Am J Obstet Gynecol 1970;106:1004–19.PubMedGoogle Scholar
  24. 24.
    Nager CW, Murphy AA. Ectopic pregnancy. Clin Obstet Gynecol 1991;34:403–11.PubMedCrossRefGoogle Scholar
  25. 25.
    Fossum GT, Davajan V, Kletzky DA. Early detection of pregnancy with transvaginal ultrasound. Fertil Steril 1988;49:788–91.PubMedGoogle Scholar
  26. 26.
    Kadar N, Caldwell BV, Romero R. A method of screening for ectopic pregnancy and its indications. Obstet Gynecol 1981;58: 162–6.PubMedGoogle Scholar
  27. 27.
    Romero R, Copel JA, Kadar N, Jeanty P, Decherney A, Hobbins JC. Value of culdocentesis in the diagnosis of ectopic pregnancy. Obstet Gynecol 1985;65:519–22.PubMedGoogle Scholar
  28. 28.
    Ory SJ. New options for diagnosis and treatment of ectopic pregnancy. JAMA 1992;267:534–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Ylöstalo P, Cacciatore B, Koskimies A, et al. Conservative treatment of ectopic pregnancy. Ann NY Acad Sci 1991;626:516–23.PubMedCrossRefGoogle Scholar
  30. 30.
    National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990;163:1689–1712.CrossRefGoogle Scholar
  31. 31.
    Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States. Am J Obstet Gynecol 1990;163:460–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Watson DL, Bhatia RK, Norman GS, Brindley BA, Sokol RJ. Bromocriptine mesylate for lactation suppression: a risk for postpartum hypertension? Obstet Gynecol 1989;74:573–6.PubMedGoogle Scholar
  33. 33.
    Wang Y, Walsh SW, Guo J, Zhang J. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991;165:1695–1700.PubMedCrossRefGoogle Scholar
  34. 34.
    Reubinoff BE, Schenker JG. HELLP syndrome—a syndrome of hemolysis, elevated liver enzymes and low platelet count—complicating preeclampsia-eclampsia. Int J Gynaecol Obstet 1991; 36:95–102.PubMedCrossRefGoogle Scholar
  35. 35.
    Sibai BM, Taslimi MM, El-Mazer A, Amon E, Mabie BC, Ryan GM. Maternal perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501–9.PubMedGoogle Scholar
  36. 36.
    Dekker GA, Sibai BM. Early detection of preeclampsia. Am J Obstet Gynecol 1991;165:160–72.PubMedCrossRefGoogle Scholar
  37. 37.
    Schiff E, Peleg E, Goldenberg M, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989;321:351–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Brown MA. Editorial review: non-pharmacological management of pregnancy-induced hypertension. J Hypertens 1990;8:295–301.PubMedCrossRefGoogle Scholar
  39. 39.
    Sibai BM, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol 1985;152:32–37.PubMedGoogle Scholar
  40. 40.
    Leduc L, Wheeler JM, Kirshon B, Mitchell P, Cotton DB. Coagulation profile in severe preeclampsia. Obstet Gynecol 1992;79:14–18.PubMedGoogle Scholar
  41. 41.
    Petrikovsky BM, Vintzileos AM. Magnesium sulfate and intrapartum fetal behavior. Am J Perinatol 1990;7:154–6.PubMedCrossRefGoogle Scholar
  42. 42.
    McCormick M. Trends in rates of low birthweight in the United States. In: Berendes HW, Kessel S, Yaffe S, editors. Advances in the prevention of low birthweight. Washington, DC: National Center for Education in Maternal and Child Health, 1991:3–11.Google Scholar
  43. 43.
    Yawn BP, Yawn RA. Preterm birth prevention in a rural practice. JAMA 1989;262:230–3.PubMedCrossRefGoogle Scholar
  44. 44.
    Lieberman E, Ryan KJ, Monson RR, Schoenbaum SC. Risk factors accounting for racial differences in the rate of premature birth. N Engl J Med 1987;317:743–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Institute of Medicine, Committee to Study the Prevention of Low Birthweight. Preventing low birthweight. Washington, DC: National Academy Press, 1985:1–37.Google Scholar
  46. 46.
    Main DM, Gabbe SG. Risk scoring for preterm labor: where do we go from here? Am J Obstet Gynecol 1987;157:789–93.PubMedGoogle Scholar
  47. 47.
    Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988;31:553–84.PubMedCrossRefGoogle Scholar
  48. 48.
    Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669–74.PubMedCrossRefGoogle Scholar
  49. 49.
    Steer PJ. Premature labor. Arch Dis Child 1991;66:1167–70.PubMedCrossRefGoogle Scholar
  50. 50.
    Utter GO, Dooley SL, Tamura RK, Socol ML. Awaiting cervical change for the diagnosis of preterm labor does not compromise efficacy of ritodrine tocolysis. Am J Obstet Gynecol 1990; 163: 882–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Papiernik E, Bouyer J, Dreyfus J, et al. Prevention of preterm births: a perinatal study in Haguenau, France. Pediatrics 1985;76: 154–8.PubMedGoogle Scholar
  52. 52.
    Herron MA, Katz M, Creasy RK. Evaluation of a preterm birth prevention program: preliminary report. Obstet Gynecol 1982;59: 452–6.PubMedGoogle Scholar
  53. 53.
    Alexander GR, Weiss J, Husley TC, Papiernik E. Preterm birth prevention: an evaluation of programs in the United States. Birth 1991;18:160–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Lorenz RP, Comstock CH, Bottoms SF, Marx SR. Randomized prospective trial comparing ultrasonography and pelvic examination for preterm labor surveillance. Am J Obstet Gynecol 1990; 162:1603–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Cabrol D, Carbonne B, Jannet D, et al. Prognostic value of cervical distensibility index measurement in the outcome of pregnancies with threatened premature labor. Gynecol Obstet Invest 1991;32: 28–32.PubMedCrossRefGoogle Scholar
  56. 56.
    Grimes DA, Schultz KF. Randomized controlled trials of home uterine activity monitoring: a review and critique. Obstet Gynecol 1992;79:137–42.PubMedGoogle Scholar
  57. 57.
    Mou SM, Sunderji SG, Gall S, et al. Multicenter randomized clinical trial of home uterine activity monitoring for detection of preterm labor. Am J Obstet Gynecol 1991;165:858–66.PubMedCrossRefGoogle Scholar
  58. 58.
    Kierse MJNC, Grant A, King J. Preterm labour. In: Chalmers I, Enkin M, Kierse MJNC, editors. Effective care in pregnancy and childbirth. Oxford: Oxford University Press, 1989:694–745.Google Scholar
  59. 59.
    Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308–12.CrossRefGoogle Scholar
  60. 60.
    Besinger RE, Niebyl JR. The safety and efficacy of tocolytic agents for the treatment of preterm labor. Obstet Gynecol Surv 1990;45:415–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Mindy A. Smith

There are no affiliations available

Personalised recommendations